Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point
- PMID: 30474162
- PMCID: PMC6357767
- DOI: 10.1111/add.14491
Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point
Abstract
There are multiple challenges toward the identification and acceptance of a meaningful reduction-based endpoint for use in drug use disorder medication efficacy clinical trials. Evaluation of change in diagnostic criteria, and severity metrics based on criterion counts, may be a promising approach for future research.
Keywords: Clinically meaningful outcome; DSM-5; functioning; negative consequences; substance use disorders; treatment end-point.
Comment on
-
What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?Addiction. 2019 Jan;114(1):9-15. doi: 10.1111/add.14289. Epub 2018 Jun 27. Addiction. 2019. PMID: 29900624 Free PMC article.
-
Don't ask apple trees to give pears.Addiction. 2019 Jan;114(1):16-17. doi: 10.1111/add.14395. Epub 2018 Aug 16. Addiction. 2019. PMID: 30117215 No abstract available.
-
Double standards and gold standards in the evaluation of how a person feels and functions in substance use disorder pharmacotherapy trials.Addiction. 2019 Jan;114(1):17-18. doi: 10.1111/add.14421. Epub 2018 Sep 11. Addiction. 2019. PMID: 30207010 No abstract available.
-
What defines a clinically meaningful outcome in the treatment of substance use disorders: 'Getting your life back'.Addiction. 2019 Jan;114(1):18-20. doi: 10.1111/add.14455. Epub 2018 Nov 13. Addiction. 2019. PMID: 30426617 No abstract available.
-
Harm reduction in opioid treatment: an established idea under threat.Addiction. 2019 Jan;114(1):20-21. doi: 10.1111/add.14468. Epub 2018 Nov 16. Addiction. 2019. PMID: 30447029 No abstract available.
References
-
- Kalk NJ Harm reduction in opioid treatment: an established idea under threat. Addiction 2019; 114: 20–1. - PubMed
-
- Volkow ND, Woodcock J, Compton WM, Throckmorton DC, Skolnick P, Hertz S et al. Medication development in opioid addiction: meaningful clinical end points. Sci Transl Med 2018; 10: eaan2595. - PubMed
-
- Witkiewitz K Double standards and gold standards in the evaluation of how a person feels and functions in substance use disorder pharmacotherapy trials. Addiction 2019; 114: 17–8. - PubMed
-
- Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient- Reported Outcomes Measurement Information System (PROMIS). Med Care 2007; 45: S22–S31. - PubMed
